NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

Tags: stem cells

This page is for our PR news release reviews tagged under “stem cells.”


Stem cell procedure marketed for erectile dysfunction, with no evidence


Examining stem cell activity in petri dishes and in rats doesn’t put us in shouting distance of a treatment for tendons


NIH gives crisp summary of early stem cell transplants for multiple sclerosis, but missed some limitations


Mayo Clinic touts ‘dramatic improvement’ in ‘surprising’ stem cell therapy study; yet placebo performed equally well


PR release on CD34+ stem cell treatment for angina raises multiple red flags


Eye stem cell treatment in people may not be as close as rat study release suggests